These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16188648)

  • 1. Juvenile myelomonocytic leukemia.
    Kratz CP; Niemeyer CM
    Hematology; 2005; 10 Suppl 1():100-3. PubMed ID: 16188648
    [No Abstract]   [Full Text] [Related]  

  • 2. Juvenile myelomonocytic leukemia.
    Emanuel PD
    Curr Hematol Rep; 2004 May; 3(3):203-9. PubMed ID: 15087069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.
    Emanuel PD
    Leukemia; 2008 Jul; 22(7):1335-42. PubMed ID: 18548091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of myeloproliferative disorder in patients with Noonan syndrome.
    Bader-Meunier B; Tchernia G; Miélot F; Fontaine JL; Thomas C; Lyonnet S; Lavergne JM; Dommergues JP
    J Pediatr; 1997 Jun; 130(6):885-9. PubMed ID: 9202609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile myelomonocytic leukemia and Noonan syndrome.
    Choong K; Freedman MH; Chitayat D; Kelly EN; Taylor G; Zipursky A
    J Pediatr Hematol Oncol; 1999; 21(6):523-7. PubMed ID: 10598665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blast-phase chronic myelomonocytic leukemia: more than just semantics.
    Patnaik MM; Tefferi A; Garcia-Manero G
    Leukemia; 2018 Sep; 32(9):2093-2094. PubMed ID: 30087420
    [No Abstract]   [Full Text] [Related]  

  • 7. [A cytogenetic and clinico-genealogical analysis of chronic myelomonocytic leukemia in a child].
    Kitsera NI; Polishchuk RS; Koziĭ RO; Sirenko AH
    Lik Sprava; 1999; (1):129-31. PubMed ID: 10424025
    [No Abstract]   [Full Text] [Related]  

  • 8. Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy.
    Emanuel PD; Shannon KM; Castleberry RP
    Mol Med Today; 1996 Nov; 2(11):468-75. PubMed ID: 8947912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From Noonan syndrome to juvenile myelomonocytic leukemia].
    Cavé H; Lachenaud J; Perez B; Verloes A; Chomienne C; Cassinat B
    Arch Pediatr; 2008 Jun; 15(5):812-3. PubMed ID: 18582761
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis and treatment of juvenile myelomonocytic leukemia(JMML)].
    Adachi S; Nakahata T
    Nihon Rinsho; 2001 Dec; 59(12):2401-6. PubMed ID: 11766346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile myelomonocytic leukemia relapsing after allogeneic bone marrow transplantation successfully treated with interferon-alpha.
    Ohta H; Kawai M; Sawada A; Tokimasa S; Fujisaki H; Matsuda Y; Osugi Y; Okada S; Hara J
    Bone Marrow Transplant; 2000 Sep; 26(6):681-3. PubMed ID: 11041570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile myelomonocytic leukemia: what we don't know.
    Smith FO; Sanders JE
    J Pediatr Hematol Oncol; 1999; 21(6):461-3. PubMed ID: 10598653
    [No Abstract]   [Full Text] [Related]  

  • 13. Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.
    Kantarjian HM; Kurzrock R; Talpaz M
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):389-404. PubMed ID: 2182598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained cytokinemia and chemokinemia concomitant with juvenile myelomonocytic leukemia in an infant with Noonan syndrome.
    Okazaki K; Unemoto J; Kondo M; Kusaka T; Kozawa K; Yoshizumi M; Shimada A; Takita J; Kaneko T; Hama T; Kimura H
    Leuk Res; 2010 Sep; 34(9):e226-8. PubMed ID: 20417558
    [No Abstract]   [Full Text] [Related]  

  • 15. Inclusion of secondary chronic myelomonocytic leukemia and myeloproliferative disease, unclassifiable, in classification of pediatric myeloproliferative disorders.
    Occhipinti E; Correa H; Yu L; Craver R
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):700-1. PubMed ID: 17023836
    [No Abstract]   [Full Text] [Related]  

  • 16. Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group.
    Manabe A; Okamura J; Yumura-Yagi K; Akiyama Y; Sako M; Uchiyama H; Kojima S; Koike K; Saito T; Nakahata T;
    Leukemia; 2002 Apr; 16(4):645-9. PubMed ID: 11960345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous remission of juvenile chronic myelomonocytic leukemia in an infant with Noonan syndrome.
    Fukuda M; Horibe K; Miyajima Y; Matsumoto K; Nagashima M
    J Pediatr Hematol Oncol; 1997; 19(2):177-9. PubMed ID: 9149755
    [No Abstract]   [Full Text] [Related]  

  • 18. JAK2 Val617Phe activating tyrosine kinase mutation in juvenile myelomonocytic leukemia.
    Tono C; Xu G; Toki T; Takahashi Y; Sasaki S; Terui K; Ito E
    Leukemia; 2005 Oct; 19(10):1843-4. PubMed ID: 16079889
    [No Abstract]   [Full Text] [Related]  

  • 19. Respiratory failure, juvenile myelomonocytic leukemia, and neonatal Noonan syndrome.
    Cheong JL; Moorkamp MH
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):262-4. PubMed ID: 17414570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia.
    Yoshimi A; Bader P; Matthes-Martin S; Starý J; Sedlacek P; Duffner U; Klingebiel T; Dilloo D; Holter W; Zintl F; Kremens B; Sykora KW; Urban C; Hasle H; Korthof E; Révész T; Fischer A; Nöllke P; Locatelli F; Niemeyer CM;
    Leukemia; 2005 Jun; 19(6):971-7. PubMed ID: 15800672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.